A detailed history of Sumitomo Mitsui Trust Holdings, Inc. transactions in Pfizer Inc stock. As of the latest transaction made, Sumitomo Mitsui Trust Holdings, Inc. holds 15,597,173 shares of PFE stock, worth $436 Million. This represents 0.3% of its overall portfolio holdings.

Number of Shares
15,597,173
Previous 15,706,951 0.7%
Holding current value
$436 Million
Previous $452 Million 4.29%
% of portfolio
0.3%
Previous 0.34%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 19, 2024

SELL
$25.89 - $29.73 $2.84 Million - $3.26 Million
-109,778 Reduced 0.7%
15,597,173 $433 Million
Q4 2023

Jan 30, 2024

BUY
$26.13 - $33.94 $3.02 Million - $3.92 Million
115,392 Added 0.74%
15,706,951 $452 Million
Q3 2023

Oct 30, 2023

SELL
$32.09 - $37.51 $5.95 Million - $6.96 Million
-185,477 Reduced 1.18%
15,591,559 $517 Million
Q2 2023

Jul 31, 2023

SELL
$36.12 - $41.79 $54.5 Million - $63 Million
-1,507,864 Reduced 8.72%
15,777,036 $579 Million
Q1 2023

Apr 27, 2023

SELL
$39.39 - $51.28 $33.4 Million - $43.5 Million
-848,833 Reduced 4.68%
17,284,900 $705 Million
Q4 2022

Jan 30, 2023

SELL
$41.75 - $54.5 $7.21 Million - $9.41 Million
-172,705 Reduced 0.94%
18,133,733 $930 Million
Q3 2022

Oct 21, 2022

SELL
$43.76 - $53.42 $4.99 Million - $6.09 Million
-114,005 Reduced 0.62%
18,306,438 $801 Million
Q2 2022

Jul 26, 2022

BUY
$46.53 - $55.17 $32.8 Million - $38.9 Million
705,664 Added 3.98%
18,420,443 $966 Million
Q1 2022

Apr 27, 2022

SELL
$45.75 - $56.69 $5.25 Million - $6.51 Million
-114,775 Reduced 0.64%
17,714,779 $917 Million
Q4 2021

Feb 02, 2022

SELL
$41.32 - $61.25 $10.7 Million - $15.8 Million
-258,007 Reduced 1.43%
17,829,554 $1.05 Billion
Q3 2021

Oct 25, 2021

BUY
$39.25 - $50.42 $407,493 - $523,460
10,382 Added 0.06%
18,087,561 $778 Million
Q2 2021

Aug 02, 2021

SELL
$35.91 - $40.68 $44.6 Million - $50.5 Million
-1,241,896 Reduced 6.43%
18,077,179 $708 Million
Q1 2021

Apr 30, 2021

SELL
$33.49 - $37.77 $6.95 Million - $7.84 Million
-207,564 Reduced 1.06%
19,319,075 $700 Million
Q4 2020

Feb 05, 2021

SELL
$33.47 - $42.56 $92.3 Million - $117 Million
-2,757,850 Reduced 12.38%
19,526,639 $719 Million
Q3 2020

Oct 30, 2020

SELL
$31.75 - $37.25 $66.6 Million - $78.2 Million
-2,098,252 Reduced 8.61%
22,284,489 $818 Million
Q2 2020

Jul 27, 2020

SELL
$30.12 - $36.54 $12.3 Million - $14.9 Million
-408,507 Reduced 1.65%
24,382,741 $797 Million
Q1 2020

Apr 27, 2020

BUY
$27.03 - $38.62 $47.6 Million - $68.1 Million
1,762,460 Added 7.65%
24,791,248 $809 Million
Q4 2019

Jan 31, 2020

BUY
$32.92 - $37.36 $17.6 Million - $20 Million
535,800 Added 2.38%
23,028,788 $902 Million
Q3 2019

Oct 31, 2019

BUY
$32.49 - $42.13 $12 Million - $15.6 Million
369,603 Added 1.67%
22,492,988 $808 Million
Q2 2019

Jul 29, 2019

SELL
$36.98 - $41.52 $41.5 Million - $46.5 Million
-1,120,903 Reduced 4.82%
22,123,385 $958 Million
Q1 2019

May 08, 2019

BUY
$37.5 - $41.2 $11.2 Million - $12.3 Million
298,220 Added 1.3%
23,244,288 $987 Million
Q4 2018

Feb 06, 2019

BUY
$38.47 - $43.86 $107 Million - $122 Million
2,786,829 Added 13.82%
22,946,068 $986 Million
Q3 2018

Nov 07, 2018

BUY
$34.47 - $41.81 $4.66 Million - $5.66 Million
135,325 Added 0.68%
20,159,239 $888 Million
Q2 2018

Aug 01, 2018

BUY
$32.98 - $35.16 $37.6 Million - $40.1 Million
1,139,678 Added 6.04%
20,023,914 $726 Million
Q1 2018

May 01, 2018

BUY
$31.91 - $37.02 $22.2 Million - $25.7 Million
695,201 Added 3.82%
18,884,236 $670 Million
Q4 2017

Feb 06, 2018

BUY
$33.26 - $35.29 $8.23 Million - $8.73 Million
247,307 Added 1.38%
18,189,035 $659 Million
Q3 2017

Nov 07, 2017

BUY
$31.0 - $34.15 $762,662 - $840,158
24,602 Added 0.14%
17,941,728 $641 Million
Q2 2017

Aug 07, 2017

BUY
N/A
17,917,126
17,917,126 $602 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $157B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Sumitomo Mitsui Trust Holdings, Inc. Portfolio

Follow Sumitomo Mitsui Trust Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sumitomo Mitsui Trust Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Sumitomo Mitsui Trust Holdings, Inc. with notifications on news.